Abiopharma

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001839882-26-041319 <b>Size:</b> 1 MB

📋 Separate Account II (Affiliate) plans to sell 104 shares of METLIFE INC (at $94.34 each, total $10K) Filed: Aug 25, 2026 | ID: 058771

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001918704-26-024658 <b>Size:</b> 590 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001918704-26-024657 <b>Size:</b> 276 KB

ALAR Investors Have Opportunity to Lead Alarum Technologies Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm

(90% Positive) ANAVEX LIFE SCIENCES CORP. (AVXL) Reports Q3 2026 Financial Results

Lakeland Fire + Safety Secures New Contract Awards Across Latin America

Satellogic to Meet with Media, Investors, and Partners in New York, Washington, D.C., San Francisco, London, and Paris Ahead of World Space Business Week

Flux Power to Participate at Upcoming Financial Conferences

(99% Neutral) BTCS INC. (BTCS) Announces Business Combination

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 0001918704-26-024656 <b>Size:</b> 457 KB

Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data SupportingTAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis

FingerMotion Notes Lyken.AI Non-Binding MOU for 128-Node B300 AI Compute Cluster